Ortin Global share price
You have to be logged in to add this to Watchlist.- ₹13.30(1.53%)March 24, 2025 15:16:51 PM IST
- NSE
- BSE
- Vol : 54.87K (NSE + BSE)Last 20 day avg : 38.85 K
Ortin Global is trading 1.53% upper at Rs 13.30 as compared to its last closing price. Ortin Global has been trading in the price range of 13.70 & 11.81. Ortin Global has given -28.29% in this year & 7.45% in the last 5 days. The company posted a net profit of -0.11 Crores in its last quarter.Listed peers of Ortin Global include Decipher Labs (-0.49%), Beryl Drugs Ord T (-2.80%), Ortin Global (1.53%).The Mutual Fund holding in Ortin Global was at -% in . The MF holding has - from the last quarter. The FII holding in Ortin Global was at 6.25% in 31 Dec 2024. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on Mar 25, 2025, 03:17 AM UTC
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BHigher than historical values3.66The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values0.00Price-to-earnings ratio based on trailing 12-month earnings
- BetaHigh volatility2.71Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.64The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is not profitable- The company's revenue fell during December quarter by 75.39% from Rs 0.14 crore to Rs 0.03 crore, year-on-year
The company has reduced its December quarter loss by 96.17% from Rs 2.79 crore to Rs 0.11 crore, year-on-year- The debt to equity of the company is higher than the industry median
- Earnings are insufficient to cover the interest expenses on outstanding debt
- R1
- 13.20
- R2
- 14.87
- R3
- 16.03
- S1
- 10.37
- S2
- 9.21
- S3
- 7.54
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Decipher Labs | Neutral | 12.13 | -0.49 | 12.26 | - | 0.56 | - | - |
| Beryl Drugs Ord T | Bearish | 23.26 | -2.80 | 11.80 | 15.96 | 1.36 | - | 26.94 |
| Ortin Global | Neutral | 13.30 | 1.53 | 10.82 | - | 3.82 | - | 63.82 |
| Unjha Formulations Ord B | Neutral | 24.00 | 1.27 | 10.75 | 38.21 | 3.89 | - | - |
| Cian Healthcare | Bearish | 3.73 | -1.84 | 9.32 | 38.40 | 0.16 | - | 47.62 |
- Promoter(s) does not have a high stake in the company
- FIIs are invested in this company
- FIIs holding is constant over the last quarter at 6.25%
- Mutual Funds are not invested in this company.
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-02-12 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
| 2024-07-31 | Others |
| 2024-05-30 | Audited Results |
- IndustryBiotechnology & Drugs
- ISININE749B01020
- BSE Code539287
- NSE CodeORTINGLOBE
Ortin Global is trading at 13.30 as on Mon Mar 24 2025 09:46:51. This is 1.53% upper as compared to its previous closing price of 13.10.
The market capitalization of Ortin Global is 10.82 Cr as on Mon Mar 24 2025 09:46:51.
The 52 wk high for Ortin Global is 24.96 whereas the 52 wk low is 10.75
Ortin Global can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: 29.43
- Dividend Yield: 0.00%
- D/E ratio: -
Ortin Global reported a net profit of -8.04 Cr in 2024.